164 related articles for article (PubMed ID: 11744025)
1. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2.
Wang W; Sawicki G; Schulz R
Cardiovasc Res; 2002 Jan; 53(1):165-74. PubMed ID: 11744025
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte.
León H; Baczkó I; Sawicki G; Light PE; Schulz R
Br J Pharmacol; 2008 Feb; 153(4):676-83. PubMed ID: 18071296
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction.
Gao CQ; Sawicki G; Suarez-Pinzon WL; Csont T; Wozniak M; Ferdinandy P; Schulz R
Cardiovasc Res; 2003 Feb; 57(2):426-33. PubMed ID: 12566115
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion.
Fert-Bober J; Leon H; Sawicka J; Basran RS; Devon RM; Schulz R; Sawicki G
Basic Res Cardiol; 2008 Sep; 103(5):431-43. PubMed ID: 18512095
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release.
Wang W; Viappiani S; Sawicka J; Schulz R
Br J Pharmacol; 2005 May; 145(1):43-9. PubMed ID: 15711589
[TBL] [Abstract][Full Text] [Related]
6. Acetaminophen attenuates peroxynitrite-activated matrix metalloproteinase-2-mediated troponin I cleavage in the isolated guinea pig myocardium.
Rork TH; Hadzimichalis NM; Kappil MA; Merrill GF
J Mol Cell Cardiol; 2006 Apr; 40(4):553-61. PubMed ID: 16530785
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury.
Sung MM; Schulz CG; Wang W; Sawicki G; Bautista-López NL; Schulz R
J Mol Cell Cardiol; 2007 Oct; 43(4):429-36. PubMed ID: 17854826
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart.
Cheung PY; Sawicki G; Wozniak M; Wang W; Radomski MW; Schulz R
Circulation; 2000 Apr; 101(15):1833-9. PubMed ID: 10769285
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.
Lalu MM; Gao CQ; Schulz R
Mol Cell Biochem; 2003 Sep; 251(1-2):61-6. PubMed ID: 14575305
[TBL] [Abstract][Full Text] [Related]
10. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts.
Yasmin W; Strynadka KD; Schulz R
Cardiovasc Res; 1997 Feb; 33(2):422-32. PubMed ID: 9074708
[TBL] [Abstract][Full Text] [Related]
11. Peroxynitrite-induced cardiac depression: role of myofilament desensitization and cGMP pathway.
Brunner F; Wölkart G
Cardiovasc Res; 2003 Nov; 60(2):355-64. PubMed ID: 14613865
[TBL] [Abstract][Full Text] [Related]
12. Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction.
Polewicz D; Cadete VJ; Doroszko A; Hunter BE; Sawicka J; Szczesna-Cordary D; Light PE; Sawicki G
J Cell Mol Med; 2011 May; 15(5):1136-47. PubMed ID: 20518849
[TBL] [Abstract][Full Text] [Related]
13. Glutathione protects against myocardial ischemia-reperfusion injury by detoxifying peroxynitrite.
Cheung PY; Wang W; Schulz R
J Mol Cell Cardiol; 2000 Sep; 32(9):1669-78. PubMed ID: 10966829
[TBL] [Abstract][Full Text] [Related]
14. Preconditioning decreases ischemia/reperfusion-induced release and activation of matrix metalloproteinase-2.
Lalu MM; Csonka C; Giricz Z; Csont T; Schulz R; Ferdinandy P
Biochem Biophys Res Commun; 2002 Aug; 296(4):937-41. PubMed ID: 12200138
[TBL] [Abstract][Full Text] [Related]
15. Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione.
Viappiani S; Nicolescu AC; Holt A; Sawicki G; Crawford BD; León H; van Mulligen T; Schulz R
Biochem Pharmacol; 2009 Mar; 77(5):826-34. PubMed ID: 19046943
[TBL] [Abstract][Full Text] [Related]
16. Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency.
Schulz R; Dodge KL; Lopaschuk GD; Clanachan AS
Am J Physiol; 1997 Mar; 272(3 Pt 2):H1212-9. PubMed ID: 9087595
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation status of matrix metalloproteinase 2 in myocardial ischaemia-reperfusion injury.
Sariahmetoglu M; Skrzypiec-Spring M; Youssef N; Jacob-Ferreira AL; Sawicka J; Holmes C; Sawicki G; Schulz R
Heart; 2012 Apr; 98(8):656-62. PubMed ID: 22397940
[TBL] [Abstract][Full Text] [Related]
18. Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury.
Chan BYH; Roczkowsky A; Cho WJ; Poirier M; Lee TYT; Mahmud Z; Schulz R
Basic Res Cardiol; 2019 Sep; 114(6):42. PubMed ID: 31506724
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide and peroxynitrite in postischemic myocardium.
Zweier JL; Fertmann J; Wei G
Antioxid Redox Signal; 2001 Feb; 3(1):11-22. PubMed ID: 11294189
[TBL] [Abstract][Full Text] [Related]
20. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury.
Schulze CJ; Wang W; Suarez-Pinzon WL; Sawicka J; Sawicki G; Schulz R
Circulation; 2003 May; 107(19):2487-92. PubMed ID: 12707244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
